[ Price : $8.95]
Federal Register Notice: FDA releases a guidance on the labeling of dietary supplements as required by the Dietary Supplement and ...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Grunenthal GmbHs tapentadol hydrochloride for the purpose...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Byrne Medical, Galderma Laboratories, and Gaven Medical.[ Price : $8.95]
FDA accepts a Johnson & Johnson Pharmaceutical Research & Developments response to a 11/08 complete response letter on an NDA for ...[ Price : $8.95]
FDAs Oncologic Drugs Advisory Committee votes 9-3 to recommend that Genzyme be required to conduct a randomized controlled trial o...[ Price : $8.95]
The Coalition or Healthcare Communication says that FDAs draft guidance on presenting risk information in promotional materials is...[ Price : $8.95]
FDA grants orphan drug status for Delcath Systems use of doxorubicin with its percutaneous hepatic perfusion technology for treati...[ Price : $8.95]
FDA approves a Watson Laboratories ANDA for Next Choice (levonorgestrel tablets 0.75 mg), a generic copy of Duramed Pharmaceutical...